PADI4 and infection: CitH3, a defining result of PAD4-mediated chromatin remodeling, has surfaced as a sensitive marker of NETosis and a prospective therapeutic target in infection-related immune dysregulation, with increased levels documented in wound infections and other chronic infections [60,61,62].